Jim Simons’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $4.56M | Buy |
+15,573
| New | +$5.12M | 0.01% | 1429 |
|
|
2025
Q3 | – | Sell |
-53,573
| Closed | -$20.8M | – | 3596 |
|
|
2025
Q2 | $20.8M | Buy |
+53,573
| New | +$21.5M | 0.03% | 698 |
|
|
2025
Q1 | – | Sell |
-122,973
| Closed | -$45.4M | – | 3552 |
|
|
2024
Q4 | $45.4M | Buy |
+122,973
| New | +$51.5M | 0.07% | 354 |
|
|
2024
Q2 | – | Sell |
-7,973
| Closed | -$4.13M | – | 3602 |
|
|
2024
Q1 | $4.13M | Sell |
7,973
-363,500
| -98% | -$181M | 0.01% | 1534 |
|
|
2023
Q4 | $175M | Sell |
371,473
-137,300
| -27% | -$63.5M | 0.27% | 68 |
|
|
2023
Q3 | $222M | Buy |
508,773
+166,100
| +48% | +$75.3M | 0.38% | 43 |
|
|
2023
Q2 | $152M | Buy |
342,673
+170,500
| +99% | +$78.7M | 0.22% | 86 |
|
|
2023
Q1 | $79.2M | Sell |
172,173
-129,900
| -43% | -$61.8M | 0.11% | 229 |
|
|
2022
Q4 | $155M | Buy |
302,073
+3,200
| +1% | +$1.62M | 0.21% | 91 |
|
|
2022
Q3 | $136M | Buy |
298,873
+239,200
| +401% | +$114M | 0.19% | 115 |
|
|
2022
Q2 | $28.8M | Buy |
+59,673
| New | +$29.5M | 0.03% | 563 |
|
|
2022
Q1 | – | Sell |
-190,373
| Closed | -$88.2M | – | 4151 |
|
|
2021
Q4 | $88.2M | Buy |
190,373
+179,300
| +1,619% | +$75.4M | 0.11% | 204 |
|
|
2021
Q3 | $4.13M | Buy |
+11,073
| New | +$4.21M | 0.01% | 1591 |
|
|
2021
Q1 | – | Sell |
-237,273
| Closed | -$76.2M | – | 3411 |
|
|
2020
Q4 | $76.2M | Buy |
237,273
+91,500
| +63% | +$28.1M | 0.08% | 246 |
|
|
2020
Q3 | $39.2M | Buy |
+145,773
| New | +$39.2M | 0.04% | 457 |
|
|
2019
Q4 | – | Sell |
-514,073
| Closed | -$123M | – | 3551 |
|
|
2019
Q3 | $123M | Buy |
+514,073
| New | +$141M | 0.1% | 211 |
|
|
2019
Q2 | – | Sell |
-275,973
| Closed | -$79.2M | – | 3594 |
|
|
2019
Q1 | $79.2M | Buy |
275,973
+248,173
| +893% | +$71.8M | 0.07% | 327 |
|
|
2018
Q4 | $7.3M | Buy |
+27,800
| New | +$7.64M | 0.01% | 1500 |
|
|
2018
Q3 | – | Sell |
-120,673
| Closed | -$28.7M | – | 3386 |
|
|
2018
Q2 | $28.7M | Sell |
120,673
-512,600
| -81% | -$119M | 0.03% | 712 |
|
|
2018
Q1 | $139M | Sell |
633,273
-38,327
| -6% | -$9M | 0.15% | 132 |
|
|
2017
Q4 | $151M | Sell |
671,600
-498,373
| -43% | -$106M | 0.17% | 119 |
|
|
2017
Q3 | $222M | Buy |
1,169,973
+302,773
| +35% | +$57.6M | 0.26% | 58 |
|
|
2017
Q2 | $163M | Sell |
867,200
-368,400
| -30% | -$66.2M | 0.21% | 86 |
|
|
2017
Q1 | $204M | Sell |
1,235,600
-451,173
| -27% | -$71.8M | 0.29% | 48 |
|
|
2016
Q4 | $243M | Buy |
1,686,773
+509,973
| +43% | +$68.3M | 0.38% | 26 |
|
|
2016
Q3 | $147M | Sell |
1,176,800
-20,173
| -2% | -$2.6M | 0.26% | 55 |
|
|
2016
Q2 | $157M | Buy |
1,196,973
+789,773
| +194% | +$108M | 0.3% | 36 |
|
|
2016
Q1 | $56.6M | Buy |
407,200
+119,300
| +41% | +$15.9M | 0.11% | 203 |
|
|
2015
Q4 | $40.1M | Sell |
287,900
-463,873
| -62% | -$63.9M | 0.09% | 269 |
|
|
2015
Q3 | $105M | Buy |
751,773
+724,473
| +2,654% | +$109M | 0.25% | 57 |
|
|
2015
Q2 | $4.48M | Buy |
+27,300
| New | +$4.36M | 0.01% | 1505 |
|
|
2015
Q1 | – | Sell |
-90,773
| Closed | -$11.4M | – | 3210 |
|
|
2014
Q4 | $11.4M | Buy |
+90,773
| New | +$11.2M | 0.03% | 801 |
|
|
2014
Q3 | – | Sell |
-779,473
| Closed | -$83.9M | – | 2821 |
|
|
2014
Q2 | $83.9M | Buy |
779,473
+433,726
| +125% | +$44.7M | 0.2% | 92 |
|
|
2014
Q1 | $34.4M | Buy |
345,747
+320,774
| +1,284% | +$29M | 0.08% | 276 |
|
|
2013
Q4 | $2.31M | Buy |
+24,973
| New | +$2.22M | 0.01% | 1679 |
|
Other funds holding ELV
VCM
VPM
Jim Simons's ELV Position: Q1 2026 in Review
Jim Simons opened a new position in Elevance Health (ELV) in Q1 2026: 15,573 shares worth $4.56M. The stake represents 0.01% of the portfolio and ranks #1429 among its holdings. This is a return to the name: Jim Simons previously reported a position in ELV as recently as Q2 2025.
Jim Simons first reported a position in ELV in Q4 2013 and has held it in 35 quarters since. The position peaked at $243M in Q4 2016. 1,467 funds tracked by Wall St. Rank hold ELV as of Q1 2026.
- Jim Simons held 15,573 shares of Elevance Health worth $4.56M as of Q1 2026.
- Elevance Health was a new Jim Simons position in Q1 2026.
- Elevance Health made up 0.01% of Jim Simons's portfolio in Q1 2026, its #1429 holding.
- Jim Simons first reported a position in Elevance Health in Q4 2013 and has held it in 35 quarters since.
- Jim Simons's Elevance Health position peaked at $243M in Q4 2016.
- 1,467 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.
Based on Renaissance Technologies's 13F filing for Q1 2026, filed 14 May 2026.